Breaking Through Healthcare's Innovation Desert: How Prenosis Built the First FDA-Authorized AI Tool for Sepsis Diagnosis

Join AI in Chicago host Khullani Abdullahi for this eye-opening conversation with Bobby Reddy Jr., CEO and co-founder of Prenosis, as he shares the remarkable 10-year journey of developing the first FDA-authorized AI tool for sepsis diagnosis.

In this episode, Bobby reveals why acute care has remained an "innovation desert" for 30 years, the critical shift from product-first to problem-first thinking, and how his team built AI that actually demands better data rather than working around missing information.

We dive deep into the unique challenges of healthcare AI, including perverse financial incentives, biological complexity, and the importance of developing transparent systems that clinicians can trust.

Bobby also shares his vision for revolutionizing clinical trials in acute care and why Chicago's grounded culture provides the perfect environment for tackling healthcare's most intractable problems.

Key Topics:

• Why acute care innovation has stagnated despite representing 10x oncology spending
• The power of problem-first vs. product-first entrepreneurship
• Building AI systems that refuse to operate with incomplete data
• The 5-year path to FDA authorization and why it matters
• Transforming clinical trials through precision medicine approaches
• Chicago's emerging role as a healthcare AI hub

Whether you're a healthcare professional, AI developer, or entrepreneur, this episode offers invaluable insights into solving complex problems that truly matter.